Stanford created a different way of stem cell therapy to deliver blood cells to reckless patients with severe cancers, promoting health rates. But sad thing happened that his discovery itself finished. A casualty of disappointing economics of marketing development of stem cell, where the detailed research, especially in the sector of personal medicine, often bothers about investing money. But now, after 10 years the technique of sale and then disregardment by a biotech firm, it is now again back in Stanford’s hands. The aim, he said, is to resume his observation to prove finally, its powerness in patients with not any hope. Weissman said that I am upset by already too much delay. So he directed again Stanford center to regenerate medicine and stem cell therapy. He also added that he is now happy because need of medicine, comparatively than fast profits, is now the vital criterion to define our discoveries of stem cell therapy.
Weissman’s determination Carried Out Positive Approach
His discovery was a procedure to isolate, cleaning and transplant of cells, known as blood-forming cells. These cells are very deep in the bone-marrow that produce the flow of life; red-cells, white-cells and platelets that flow in our arteries & veins. His aim is to utilize them to reproduce victims’ blood-forming programs after intensive chemotherapy. A medicine amount strong enough to destroy tumor cells kills blood-forming stem-cells and finally the patient too. But only if the cells get extracted from the bone-marrow of patient just before the process of treatment, removal of cancer and then put back to the patient’s body after the chemotherapy, they can be surely lifesaving. In reality, patients can rebuild their supply of blood from the scratch definitely. Weissman also co-founded a company named Systemix to advertise his approach. And finally in an adventurous departure from historic procedures, he dominated not only his approach, and also the stem cell therapy.
Demand By Pharma Investors
In the first chance a woman with severe breast tumor at Stanford, received intensive chemotherapy, chased by Weissman’s plan with stem cells purified itself. Significantly, that improved the chances of good survival. After diagnosing for twelve years, thirty-three percent of ladies with breast cancers were still enjoying good lives comparing with the ladies who got treatment without purification of cells. The most common medical remark is that transplantation of stem cell coupled with immense-dose of chemotherapy doesn’t work for the victim of breast tumor. But in a case when stem cells get purified to destroy the cancer cells, by using Weissman’s technique, outcomes are convincing and good. This approach made Weissman a multimillionaire. But his technique was put behind. His program ended in 2000 because the non-production of blood stem cells at large scales in business market.Once you prove the efficacy of your approach the big dealers of Pharma cannot put it behind in the shelf. But you required to prove its effectiveness just before you give it. Weissman perceivedthat the success just slipping down through his hands.